Suominen Corporation
Suominen Corporation February 25, 2021 at 4:30 p.m. (EEST)
Suominen Corporation - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Saim, Mimoun
Position: Other senior manager
Issuer: Suominen Corporation
LEI: 743700Z1BNFYR9PRDF52
Notification type: INITIAL NOTIFICATION
Reference number: 743700Z1BNFYR9PRDF52_20210225082607_2
____________________________________________
Transaction date: 2021-02-25
Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)
Instrument type: SHARE
ISIN: FI0009010862
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION
Transaction details
(1): Volume: 5,387 Unit price: N/A
Aggregated transactions
(1): Volume: 5,387 Volume weighted average price: N/A
SUOMINEN CORPORATION
For more information, please contact
Emilia Peltola, Vice President, Communications & IR, Suominen Corporation, tel. +358 50 540 9747
Suominen manufactures nonwovens as roll goods for wipes and other applications. Our vision is to be the frontrunner for nonwovens innovation and sustainability. The end products made of Suominen’s nonwovens are present in people’s daily life worldwide. Suominen’s net sales in 2020 were EUR 458.9 million and we have nearly 700 professionals working in Europe and in the Americas. Suominen’s shares are listed on Nasdaq Helsinki. Read more at www.suominen.fi.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sveriges Riksbank1.7.2025 10:15:00 CEST | Press release
RESULT OF RIKSBANK CERTIFICATE SALE
ProLogium Technology Co., Ltd.1.7.2025 10:05:16 CEST | Press release
ProLogium’s Next-Generation Lithium Ceramic Battery Shipments Surpass 2.4 Million Units
Alvotech1.7.2025 10:00:00 CEST | Press release
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
Virtune AB (Publ)1.7.2025 09:30:54 CEST | Press release
Virtune is listing Virtune Coinbase 50 Index ETP on Euronext Amsterdam and Paris
Investeringsforeningen PortfolioManager1.7.2025 09:30:06 CEST | Pressemeddelelse
Investeringsforeningen PortfolioManager suspenderer handel med afdeling/andelsklasse
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom